14-104774548-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001382430.1(AKT1):​c.633+390G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.562 in 255,446 control chromosomes in the GnomAD database, including 44,426 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.61 ( 31055 hom., cov: 34)
Exomes 𝑓: 0.49 ( 13371 hom. )

Consequence

AKT1
NM_001382430.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.80

Publications

13 publications found
Variant links:
Genes affected
AKT1 (HGNC:391): (AKT serine/threonine kinase 1) This gene encodes one of the three members of the human AKT serine-threonine protein kinase family which are often referred to as protein kinase B alpha, beta, and gamma. These highly similar AKT proteins all have an N-terminal pleckstrin homology domain, a serine/threonine-specific kinase domain and a C-terminal regulatory domain. These proteins are phosphorylated by phosphoinositide 3-kinase (PI3K). AKT/PI3K forms a key component of many signalling pathways that involve the binding of membrane-bound ligands such as receptor tyrosine kinases, G-protein coupled receptors, and integrin-linked kinase. These AKT proteins therefore regulate a wide variety of cellular functions including cell proliferation, survival, metabolism, and angiogenesis in both normal and malignant cells. AKT proteins are recruited to the cell membrane by phosphatidylinositol 3,4,5-trisphosphate (PIP3) after phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) by PI3K. Subsequent phosphorylation of both threonine residue 308 and serine residue 473 is required for full activation of the AKT1 protein encoded by this gene. Phosphorylation of additional residues also occurs, for example, in response to insulin growth factor-1 and epidermal growth factor. Protein phosphatases act as negative regulators of AKT proteins by dephosphorylating AKT or PIP3. The PI3K/AKT signalling pathway is crucial for tumor cell survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating AKT1 which then phosphorylates and inactivates components of the apoptotic machinery. AKT proteins also participate in the mammalian target of rapamycin (mTOR) signalling pathway which controls the assembly of the eukaryotic translation initiation factor 4F (eIF4E) complex and this pathway, in addition to responding to extracellular signals from growth factors and cytokines, is disregulated in many cancers. Mutations in this gene are associated with multiple types of cancer and excessive tissue growth including Proteus syndrome and Cowden syndrome 6, and breast, colorectal, and ovarian cancers. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020]
AKT1 Gene-Disease associations (from GenCC):
  • Proteus syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden syndrome 6
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.882 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AKT1NM_001382430.1 linkc.633+390G>C intron_variant Intron 8 of 14 ENST00000649815.2 NP_001369359.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AKT1ENST00000649815.2 linkc.633+390G>C intron_variant Intron 8 of 14 NM_001382430.1 ENSP00000497822.1

Frequencies

GnomAD3 genomes
AF:
0.610
AC:
92769
AN:
152066
Hom.:
31009
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.890
Gnomad AMI
AF:
0.333
Gnomad AMR
AF:
0.637
Gnomad ASJ
AF:
0.415
Gnomad EAS
AF:
0.649
Gnomad SAS
AF:
0.624
Gnomad FIN
AF:
0.491
Gnomad MID
AF:
0.487
Gnomad NFE
AF:
0.463
Gnomad OTH
AF:
0.587
GnomAD4 exome
AF:
0.491
AC:
50700
AN:
103262
Hom.:
13371
Cov.:
0
AF XY:
0.494
AC XY:
25976
AN XY:
52630
show subpopulations
African (AFR)
AF:
0.886
AC:
3017
AN:
3404
American (AMR)
AF:
0.640
AC:
3064
AN:
4790
Ashkenazi Jewish (ASJ)
AF:
0.416
AC:
1460
AN:
3510
East Asian (EAS)
AF:
0.601
AC:
4136
AN:
6878
South Asian (SAS)
AF:
0.553
AC:
4462
AN:
8064
European-Finnish (FIN)
AF:
0.477
AC:
2201
AN:
4618
Middle Eastern (MID)
AF:
0.494
AC:
258
AN:
522
European-Non Finnish (NFE)
AF:
0.444
AC:
28919
AN:
65094
Other (OTH)
AF:
0.499
AC:
3183
AN:
6382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1166
2332
3497
4663
5829
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
286
572
858
1144
1430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.610
AC:
92871
AN:
152184
Hom.:
31055
Cov.:
34
AF XY:
0.613
AC XY:
45570
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.890
AC:
36976
AN:
41552
American (AMR)
AF:
0.638
AC:
9756
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.415
AC:
1440
AN:
3472
East Asian (EAS)
AF:
0.649
AC:
3348
AN:
5162
South Asian (SAS)
AF:
0.624
AC:
3013
AN:
4828
European-Finnish (FIN)
AF:
0.491
AC:
5204
AN:
10592
Middle Eastern (MID)
AF:
0.469
AC:
137
AN:
292
European-Non Finnish (NFE)
AF:
0.463
AC:
31454
AN:
67968
Other (OTH)
AF:
0.587
AC:
1239
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1675
3350
5026
6701
8376
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
738
1476
2214
2952
3690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.402
Hom.:
1164
Bravo
AF:
0.633
Asia WGS
AF:
0.662
AC:
2301
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.34
DANN
Benign
0.38
PhyloP100
-1.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2494734; hg19: chr14-105240885; COSMIC: COSV62575113; COSMIC: COSV62575113; API